drugset / Trial / NCT00228475

A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women

NCT00228475

Phase 4 Completed 8 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose to measure the concentration of budesonide in breast milk of asthmatic mothers on their normal maintenance treatment with budesonide (Pulmicort Turbuhaler), and to estimate the exposure of budesonide to infants.

Timeline

Start
2004-09
Primary completion
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 200 ug
Subject Budesonide Small molecule 400 ug

Indications